|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biological Engineering Division (M.H.C., P.L.S., J.S.W., S.R.T.), and Department of Chemistry (S.R.T.), Massachusetts Institute of Technology, Cambridge, Massachusetts
A combination of accelerator mass spectrometry (AMS) and liquid chromatography-tandem mass spectrometry has been used to clarify some new aspects of testosterone metabolism. The main pathway of testosterone oxidative metabolism by human liver microsomes is the formation of 1ß-, 2
-/ß-, 6ß-, 15ß-, and 16ß-hydroxytestosterones, mainly catalyzed by cytochromes P450 2C9, 2C19, and 3A4. We now report the first determination that 11ß-hydroxytestosterone (11ß-OHT) can also be formed by human liver microsomal fractions. The structures of five hydroxylated metabolites of testosterone (2ß-, 6ß-, 11ß-, 15ß-, and 16ß-OHT) and the C-17 oxidative metabolite androstenedione were determined by liquid chromatography with UV detection at 240 nm and liquid chromatography-tandem mass spectrometry. Corresponding results were obtained by high-performance liquid chromatography-AMS analysis of incubations of [4-14C]testosterone with human liver microsomes. 6ß-Hydroxylation was always the dominant metabolic pathway, but 2ß-, 15ß-, and 16ß-OHT, and androstenedione were also formed. The previously undetected hydroxytestosterone, 11ß-OHT, was found to be a minor metabolite formed by human liver microsomal enzymes. It was formed more readily by CYP3A4 than by either CYP2C9 or CYP2C19. 11ß-Hydroxylation was inhibited by ketoconazole (IC50 = 30 nM) at concentrations similar to the IC50 (36 nM) for 6ß-hydroxylation Therefore, CYP3A4 could be mainly responsible for testosterone 11ß-hydroxylation in the human liver. These findings identify human hepatic biotransformation of testosterone to 11ß-OHT as a previously unrecognized extra-adrenal metabolic pathway.
This article has been cited by other articles:
![]() |
S. K. Balani, N. V. Nagaraja, M. G. Qian, A. O. Costa, J. S. Daniels, H. Yang, P. R. Shimoga, J.-T. Wu, L.-S. Gan, F. W. Lee, et al. EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY Drug Metab. Dispos., March 1, 2006; 34(3): 384 - 388. [Abstract] [Full Text] [PDF] |
||||